Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | %Female (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
68 | Pharmacy in Practice | journal | 0.108 Q4 | 6 | 21 | 84 | 70 | 6 | 49 | 0.02 | 3.33 | 20.00 | |
67 | Journal of Applied Therapeutic Research | journal | 0.109 Q4 | 8 | 8 | 43 | 155 | 4 | 43 | 0.09 | 19.38 | 29.41 | |
66 | Drugs in R and D | journal | 0.116 Q4 | 54 | 0 | 240 | 0 | 39 | 240 | 0.16 | 0.00 | 0.00 | |
65 | Expert Opinion on Pharmacotherapy | journal | 0.119 Q4 | 93 | 89 | 16 | 6820 | 4 | 16 | 0.25 | 76.63 | 17.09 | |
64 | British journal of clinical practice. Supplement | journal | 0.121 Q4 | 1 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
63 | Journal of Clinical Research | journal | 0.121 Q4 | 12 | 6 | 50 | 83 | 15 | 50 | 0.30 | 13.83 | 19.23 | |
62 | IDrugs : the investigational drugs journal | journal | 0.144 Q3 | 39 | 69 | 241 | 5920 | 63 | 237 | 0.26 | 85.80 | 14.14 | |
61 | Expert Opinion on Therapeutic Targets | journal | 0.146 Q3 | 106 | 44 | 158 | 5137 | 29 | 156 | 0.32 | 116.75 | 18.63 | |
60 | Pharmacology Reviews and Communications | journal | 0.158 Q3 | 9 | 11 | 73 | 339 | 16 | 73 | 0.28 | 30.82 | 17.24 | |
59 | Pharmacology and Toxicology, Supplement | journal | 0.170 Q3 | 7 | 10 | 41 | 246 | 9 | 41 | 0.19 | 24.60 | 11.11 | |
58 | BioDrugs | journal | 0.187 Q3 | 79 | 81 | 251 | 5271 | 174 | 240 | 0.79 | 65.07 | 28.21 | |
57 | Pharmaceutical Biology | journal | 0.193 Q3 | 88 | 76 | 292 | 1581 | 67 | 288 | 0.13 | 20.80 | 48.72 | |
56 | Paediatric and Perinatal Drug Therapy | journal | 0.197 Q3 | 20 | 17 | 121 | 264 | 27 | 120 | 0.57 | 15.53 | 39.29 | |
55 | Pharmaceutical Medicine | journal | 0.210 Q3 | 25 | 68 | 179 | 473 | 34 | 132 | 0.18 | 6.96 | 17.14 | |
54 | Pharmaceutical Journal | journal | 0.218 Q3 | 28 | 302 | 1174 | 2157 | 151 | 605 | 0.13 | 7.14 | 45.00 | |
53 | Reviews in Contemporary Pharmacotherapy | journal | 0.229 Q3 | 18 | 17 | 93 | 2155 | 94 | 93 | 1.13 | 126.76 | 21.74 | |
52 | Pharmacology Communications | journal | 0.234 Q3 | 8 | 0 | 28 | 0 | 11 | 28 | 0.00 | 0.00 | 0.00 | |
51 | Acta Pharmacologica Sinica | journal | 0.238 Q3 | 117 | 218 | 517 | 3925 | 292 | 517 | 0.56 | 18.00 | 29.66 | |
50 | Expert Opinion on Emerging Drugs | journal | 0.243 Q3 | 54 | 25 | 63 | 2057 | 49 | 61 | 0.80 | 82.28 | 32.69 | |
49 | International Antiviral News | journal | 0.249 Q3 | 8 | 23 | 103 | 756 | 40 | 69 | 0.44 | 32.87 | 13.04 | |
48 | Pharmacy and Pharmacology Communications | journal | 0.260 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
47 | Current Opinion in Molecular Therapeutics | journal | 0.283 Q3 | 67 | 90 | 93 | 4584 | 63 | 87 | 0.68 | 50.93 | 22.83 | |
46 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.291 Q3 | 57 | 36 | 113 | 840 | 60 | 105 | 0.51 | 23.33 | 15.56 | |
45 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.303 Q3 | 81 | 59 | 186 | 2060 | 150 | 169 | 0.93 | 34.92 | 32.80 | |
44 | Journal of Pharmacy and Pharmacology | journal | 0.310 Q3 | 137 | 569 | 1617 | 8068 | 1109 | 1580 | 0.60 | 14.18 | 27.14 | |
43 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.311 Q3 | 25 | 25 | 44 | 685 | 40 | 29 | 0.59 | 27.40 | 23.08 | |
42 | Immunopharmacology and Immunotoxicology | journal | 0.311 Q3 | 61 | 45 | 128 | 1523 | 129 | 128 | 0.95 | 33.84 | 35.48 | |
41 | Autonomic and Autacoid Pharmacology | journal | 0.317 Q3 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
40 | Journal of Food Biochemistry | journal | 0.323 Q2 | 64 | 34 | 93 | 867 | 59 | 93 | 0.53 | 25.50 | 37.89 | |
39 | Biopharmaceutics and Drug Disposition | journal | 0.336 Q2 | 65 | 42 | 210 | 1010 | 180 | 207 | 0.89 | 24.05 | 24.81 | |
38 | Phytotherapy Research | journal | 0.336 Q2 | 158 | 137 | 530 | 3221 | 279 | 527 | 0.52 | 23.51 | 40.42 | |
37 | ChemMedChem | journal | 0.352 | 119 | 118 | 355 | 2163 | 235 | 354 | 0.68 | 18.33 | 44.96 | |
36 | Expert Opinion on Investigational Drugs | journal | 0.365 Q2 | 117 | 278 | 449 | 19174 | 510 | 446 | 1.17 | 68.97 | 20.63 | |
35 | Tumor Targeting | journal | 0.404 Q2 | 10 | 0 | 54 | 0 | 56 | 52 | 1.04 | 0.00 | 0.00 | |
34 | Antiviral Therapy | journal | 0.409 Q2 | 93 | 39 | 201 | 566 | 151 | 184 | 0.92 | 14.51 | 30.06 | |
33 | Fundamental and Clinical Pharmacology | journal | 0.410 Q2 | 85 | 62 | 276 | 2075 | 282 | 273 | 1.25 | 33.47 | 33.62 | |
32 | International Journal of Neuropsychopharmacology | journal | 0.432 Q2 | 125 | 47 | 66 | 1989 | 65 | 66 | 0.98 | 42.32 | 27.39 | |
31 | Expert Opinion on Therapeutic Patents | journal | 0.439 Q2 | 88 | 150 | 402 | 6755 | 392 | 397 | 1.04 | 45.03 | 17.93 | |
30 | Journal of Chemotherapy | journal | 0.456 Q2 | 56 | 111 | 292 | 2182 | 328 | 285 | 1.13 | 19.66 | 40.48 | |
29 | Mathematical Medicine and Biology | journal | 0.497 Q2 | 49 | 21 | 61 | 545 | 69 | 61 | 0.88 | 25.95 | 20.00 | |
28 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.498 Q2 | 92 | 37 | 111 | 1330 | 179 | 111 | 1.84 | 35.95 | 31.46 | |
27 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.521 Q2 | 67 | 60 | 206 | 1509 | 186 | 205 | 0.72 | 25.15 | 36.11 | |
26 | Biomedical Chromatography | journal | 0.578 Q2 | 71 | 95 | 308 | 1955 | 306 | 306 | 0.91 | 20.58 | 30.82 | |
25 | Xenobiotica | journal | 0.594 Q2 | 89 | 88 | 285 | 2603 | 534 | 284 | 2.13 | 29.58 | 23.23 | |
24 | PharmacoEconomics | journal | 0.623 Q2 | 118 | 113 | 412 | 4645 | 734 | 381 | 1.74 | 41.11 | 27.76 | |
23 | Cytokines, Cellular and Molecular Therapy | journal | 0.626 Q2 | 28 | 29 | 82 | 1099 | 145 | 81 | 1.67 | 37.90 | 22.77 | |
22 | Antiviral Chemistry and Chemotherapy | journal | 0.650 Q2 | 59 | 38 | 160 | 1506 | 338 | 159 | 2.39 | 39.63 | 38.37 | |
21 | Clinical and Experimental Pharmacology and Physiology | journal | 0.660 Q1 | 115 | 184 | 604 | 6587 | 1007 | 603 | 1.65 | 35.80 | 26.93 | |
20 | Journal of Peptide Science | journal | 0.668 Q1 | 73 | 61 | 148 | 1971 | 196 | 145 | 1.49 | 32.31 | 30.29 | |
19 | Current Opinion in Drug Discovery and Development | journal | 0.669 Q1 | 85 | 77 | 83 | 3924 | 161 | 78 | 1.94 | 50.96 | 16.92 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®